Literature DB >> 31913144

Continuous Renal Replacement Therapy Without Anticoagulation: Top Ten Tips to Prevent Clotting.

Ian Baldwin1, Daryl Jones2, Paula Carty2, Nigel Fealy2.   

Abstract

Continuous renal replacement therapy (CRRT) is intended to function continuously and is prescribed for this outcome. Anticoagulants may not always be used. Clotting and clogging within the CRRT filter stopping therapy occurs with a variability in the total elapsed time associated. This is commonly known as the circuit or filter "life". It is very useful and important to record this time at the bedside and refer to this as a measure of success and quality. Filter life (i.e., hours) is reported in many reports investigating CRRT but is not well understood or clear for when this is considered inadequate and clinical review strategies should be considered. Failure before 8 h could be associated with inadequate renal support and "therapy". Anticoagulation is the key intervention to prolong filter function; however, the extracorporeal circuit design and set up, access catheter profile and insertion site, CRRT machine settings, and the human interface operating CRRT are always important and the only consideration to prevent failure when no anticoagulation is mandated for CRRT.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Clotting; Continuous renal replacement therapy; Filter life; Hemofiltration; Intensive care unit; Nursing

Mesh:

Substances:

Year:  2020        PMID: 31913144     DOI: 10.1159/000505260

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  2 in total

1.  Dialysis Filter Life, Anticoagulation, and Inflammation in COVID-19 and Acute Kidney Injury.

Authors:  Yuang Wen; Jason R LeDoux; Muner Mohamed; Akanksh Ramanand; Kevin Scharwath; Destiney Mundy; Ivo Lukitsch; Juan Carlos Q Velez
Journal:  Kidney360       Date:  2020-10-20

2.  Research on the Effect of 5Why-Based Nursing Intervention in Blood Purification Nursing.

Authors:  Ru Cai; Yun Fei; XiaoPing Li; LinFang Xu; Chun Lei Wu; Na Wu
Journal:  J Healthc Eng       Date:  2021-09-24       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.